Portuguese Proteomics Network
Rede Proteómica Portuguesa



 



The intention to create the ProCura network started in the beginning of 2001, when the research group, Grupo de Investigação em Fibrose Quística, Centro de Genética Humana, Instituto Nacional de Saúde Dr Ricardo Jorge (coordinated by Deborah Penque and Margarida Amaral) invited two others, Laboratório de Química, Universidade de Aveiro (coordinated by Ferrer Correia and represented by Francisco Amado and Pedro Domingues) and Unidade de Bioinformática, Instituto Gulbenkian de Ciência (coordinated by Pedro Fernandes) to join in a collaborative proteomics research project.
ProCura is conducting now a survey of existing proteomics efforts in Portugal. The aim is to bring together Portuguese laboratories to form a collaborative platform on the functional proteomics technology. Each participating laboratory will have the opportunity to share and use the benefits of proteomics to develop its own basic research programs in different areas, such as molecular and cell biology, biochemistry, biophysics, bioinformatics and clinical research.

ProCura- Research Institution Members
Laboratório de Proteómica - CGH/INSA-Ricardo Jorge - Lisbon
Group of Hemoglobinopaties (Hb) - CGH/INSA-Ricardo Jorge - Lisbon
Bioinformatic Unit - IGC
Instituto de Biologia Molecular e Celular do Porto (IBMC) - Departament of Molecular Neurobiology
Mass Spectometry Laboratory - ITQB/IBET
Molecular Biology Laboratory - Institute of Hygiene and Tropical Medicine
Centro de Malária e outras Doenças Tropicais, U.E.I. Malária, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa – Host-parasite interactions

 

ProCura-University Members

Departament of Chemistry, University of Aveiro

REQUIMTE Laboratório Associado, CQFB, Departamento de Química (FCT/UNL)

 

ProCura- Research Institution Members

Laboratório de Proteómica
Centro de Genética Humana
Instituto Nacional de Saúde Dr Ricardo Jorge (CGH/INSA)
1649-016 Lisboa Portugal

Missions

- Developing an innovative proteomics technical platform to the diagnosis, prognosis and assessment of infectious and degenerative chronic diseases.
- Developing a integrate researcher for the elucidation of diseases, namely, the chronic lung diseases [cystic, fibrosis, asthma, chronic obstructive pulmonary disease (COPD)] and cancer disease (lung and liver cancers), as well as to the identification of new biomarkers and/or therapeutic targets. The ultimate goal is to provide the INSA with new diagnostic and prognostic tools based on proteomics allowing clinicians to truly tailor therapy.
- Contributing to the proteomics dissemination and application in our country, trough the promotion of courses, laboratory trainings, conferences and national and international networking.


Current Projects

2005-2006 Proteomics of Chronic Lung Diseases: Leading to Biomarkers and Therapeutic Target Discovery.
Project suportted by Fundação da Ciência e a Tecnologia (FCT) (POCTI/SAU-MMO/56163/2004).
Principal Investigator: D Penque, LP/CGH-INSA

2002- 2006 Proteome Analysis of Cystic Fibrosis Transgenic Mice.
Project suportted by Fundação da Ciência e a Tecnologia (POCTI/ESP/44720/2002).
Principal Investigator: D Penque, LP/CGH-INSA

2006-2007 Is the MicroRNA-122 specific determinant for HCV virus replication in the chronic liver hepatitis?
Project rewarded in 2006 with a research grant of Associação Portuguesa para o Estudo do Fígado (sponsored by Roche-Portugal Lda).
Coordinator of the projecto: Jorge Peneda, UA/CBP-INSA.
Principal Investigator Principal: D Penque, LP/CGH-NSA.

2007- 2008 Autoimmunity in Behçet's Disease - a Proteomics Approach.
Project suportted by Instituto Nacional de Saúde Dr. Ricardo Jorge (BIC/07/2004-IV).
Principal Investigator: L Costa, UIDI/CBP-INSA / D Penque, LP/CGH-INSA


Team

Deborah Penque, Reseacher Lab Coordinator

Mª Fátima Vaz, Principal Assistant of Technical Healthy Career Lab Technical Responsible

Tânia Simões, Post-Doctoral Fellow (FCT* )

Isabel Carvalho-Oliveira, Doctoral Fellow (FCT*)

Patrícia Gomes Alves, Doctoral Fellow (FCT*)

Bruno M. Alexandre, Doctoral Fellow (FCT*)

Nuno Miguel Charro, Doctoral Fellow (FCT*)

Judite Marques Dias, Doctoral Fellow (FCT*)

João Banha, Research Fellow INSA

Sofia Neves, Research Fellow APEF**

*Fundação da Ciência e a Tecnologia; **Associação Portuguesa para o Estudo do Fígado

Top


Group of Hemoglobinopaties (Hb)
Centro de Genética Humana
Instituto Nacional de Saúde Dr Ricardo Jorge (CGH/INSA)
1649-016 Lisboa Portugal

For the last ten years, this group has been actively involved in studying the molecular basis of alfa- and ß-thalassemia in the Portuguese population, by investigating a number of genetic alterations associated with hemoglobin disorders, both at the genomic and functional levels. Presently, our studies are specifically focused on the role of mRNA stability in the control of human globin gene expression. In this context, we are developing the following projects:
1. The study of the mechanism by which human normal ß-globin mRNA is stabilized in erythroid cells.
2. The study of the human ß-globin mRNA nonsense-mediated decay mechanism.
3. The study of the human alfa-globin mRNA nonsense-mediated decay mechanism.
4. The suppression of premature stop codons in the human ß-globin gene induced by pharmacological treatment.
Responsible: Luisa Romão

Top


Instituto Gulbenkian de Ciência (UB/IGC) - Unidade de Bioinformática

The operating team of this Unit is responsible for the Portuguese node of the EMBnet for the last ten years, delivering to many users a service that consists of providing access to periodically updated copies of about 30 databases of sequence data, a suite of correctly installed and documented programs to process them and user support via e-mail or telephone. Specific bridging competence in the genomics/proteomics area is presently one of the major targets of the current investments in both tools and human expertise. The ProCura network is expected to bring in some of the most challenging opportunities to field test and deploy such facilities in full contact with the user community.
Responsible: Pedro Fernandes

Top

Instituto de Biologia Molecular e Celular do Porto (IBMC) - Departamento de Neurobiologia Molecular

Molecular Neurobiology
Basic and Clinical Neurobiology

Group Leader: Maria João Saraiva , PhD (Biomedical Inst. U.P.)

Principal Investigators:
MR Almeida, PhD (Biomedical Inst. U.P.)
JA Palha, PhD (Health Sc, University of Braga, Adjunct Investigator)
MM Sousa, PhD (IBMC, U.P.)

This unit had its origins in 1997 with a background on studies on familial amyloidotic polyneuropathy (FAP), a peculiar form of neuropathy first described by the eminent Portuguese neurologist Corino de Andrade, which is characterized by the deposition of amyloid in special on the peripheral nerves. This autosomal dominant disease is a health problem in the country. The unit is devoted to laboratorial investigation on FAP on epidemiological, biochemical, genetic and pathological aspects, as well as on the biology of transthyretin- TTR (represented in the figure), a serum protein that when mutated is the major defect underlying FAP.
The main objective of the team are the identification and characterization of ethio-physiopathological mechanisms of FAP and the search for preventive, diagnostic and treatment forms. The technologies developed for these purposes are used, however, in studies of other TTR related disorders, in basic research of human physiology specially those associated with transport of thyroid hormones and vitamin A, natural ligands of TTR, and in general with TTR.

 

ITQB/IBET - Mass Spectometry Laboratory

Coordinator: Ana Coelho, PhD (labms@itqb.unl.pt)

The ITQB/IBET Mass Spectrometry Laboratory performs internal and external services and related research work. The laboratory installation process started in October 2002 aiming to be certified as a GLP unit. At the moment we perform mass determination, structural and affinity studies for a broad range of chemical compounds, from small organic and organometalic compounds to peptides, oligosacharides, nucleotides and proteins. The information obtained with the powerful mass spectrometry techniques is fundamental for the structural characterization of chemical and biochemical species. Else than precise mass determination it is possible to perform controlled fragmentation of the molecular ions, which allows to get detailed structural information, like comparative identification of organic compounds, peptide and oligosacharide sequencing, characterization of post-translational modifications: these are the so called MS/MS or tandem mass spectrometry experiments. The mass spectrometry results are important, for example, in monitoring chemical synthesis, purification and identification of chemical and biochemical compounds, metabolic and kinetic studies.

Instrumentation

Thermofinnigan LCQ ion-trap coupled to an HPLC system with the folowing ion sources:
- ESI (Electrospray Ionisation)
- APCI (Atmosferic Pressure Chemical Ionization)

Bruker Esquire 3000plus ion-trap with the folowing ion sources:
- ESI (Electrospray Ionisation)
- ESI (Nanoelectrospray)
- APCI (Atmosferic Pressure Chemical Ionization)

Applied Biosystem Voyager STR MALDI-TOF with reflectron

ITQB Analytical Services

* Mass Spectrometry

* Protein Sequencing

* Elemental Analysis

* Amino Acid Analysis

* Small Molecule X-ray Crystallography

 

Molecular Biology Laboratory - Institute of Hygiene and Tropical Medicine

Rua da Junqueira, 96
1349-008 Lisboa Portugal


The Proteomics of Delta Hepatitis

The Hepatitis delta virus (HDV) is the causative agent of one of the most severe forms of virus hepatitis, being endemic in several regions of the world. This virus is the smallest human pathogen known so far. It's 1,7 Kb, circular, ss RNA genome – strikingly similar to that of plant viroids -encodes for a single protein that is expressed in two forms as a result of an RNA editing mechanism. Despite being so simple, very little is known about the cellular factors involved in virus replication and biogenesis as well as the pathogenic mechanisms that may cause different disease forms: fulminant hepatitis, cirrhosis, chronic hepatitis. In this project we intend to identify changes in cellular gene expression at the protein level, that arise upon HDV infection, and transient transfection of hepatoma cells with cDNAs encoding the HDV components (RNA, and both forms of antigens). Accomplishment of this goal will hopefully help to shad light on the virus life cycle, and identify novel targets for a specific therapy. Project coordinator: Celso Cunha; Molecular Biology Unit, Institute of Hygiene and Tropical Medicine, Lisbon, Portugal (ccunha@ihmt.unl.pt)

Top

Centro de Malária e outras Doenças Tropicais, U.E.I. Malária, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa – Host-parasite interactions

Rua da Junqueira, 96
1349-008 Lisboa
Tel: +351 213652657
Fax: +351 213622458

Missions

Malaria is a life threatening disease that kills over a million each year. The parasite that causes it has a complex life cycle involving a vertebrate host and a mosquito vector. Most efforts have been put in controlling malaria in the vertebrate host. Even so, an efficacious malaria vaccine is far from being achieved and anti-malarial resistance have been spreading globally. Therefore, complementary malaria control strategies acting on the vector are urgently needed. Identification of mechanisms of infection control and how they can be modulated will permit, in the long run, the development of transmission blocking strategies. In this frame our research is focused on the 1) influence of blood meal components on the outcome of Plasmodium infection in the mosquito; and 2) characterization of mosquito immune response to Plasmodium infection.
Using genomic approaches we established an undoubtful association between chloroquine treatment and alterations in mosquito immune response that may justify alterations in infectivity of Plasmodium to the mosquito.
Our current aims are to 1) identify and characterize hemolymph proteins that are involved in mosquito response to Plasmodium sporozoites; 2) Characterize serine proteases activity during Plasmodium infection [in collaboration with Ana Domingos, INETI]. 3) characterize mosquito immune molecules associate with parasite recognition using Lab and field approaches.


Current Projects

2003-2006 The effect of chloroquine on the modulation of mosquito vector response to Plasmodium infection. ref:POCTI/MGI/344905/2002

2006-2007 Gene variability of pattern-recognition-molecules (PRM) involved in mosquito immune response to Plasmodium. ref: POCI/SAU-IMI/59489/2004

Team

Henrique Silveira, Principal Investigador

Susana Ramos, PhD Student (FCT*)

Luis Filipe Lopes, PhD Student (FCT*)

Patrícia Abrantes, PhD Student (FCT*)

Rute Felix, PhD Student (FCT*)

Bianor Valente, MSc Student

* Fundação da Ciência e a Tecnologia PhD fellowship

Top

ProCura-University Members

Universidade de Aveiro

Departamento de Química (DQ/UA)

Since its firsts steps in 1975 of the Mass Spectrometer group at the University of Aveiro the members of our lab are interested in a variety of areas of mass spectrometry. Our focuses include research on the gas phase ion chemistry and biological mass spectrometry. Research projects are from the development of the application of ESI and nano-ESI to Proteomics, Oxidative stress, Biogenic amines and Coordenation compounds and to the fundamental studies of ion energetics.

Instrumentation

Q-TOF II mass spectometer with the folowing ion sources:
- ESI (Electrospray Ionisation)
- ESI (Nanoelectrospray)
- APCI (Atmosferic Pressure Chemical Ionization)

Mass spectometer AUTOSPEQ (EBEqQ) with the folowing ion sources:
- ESI (Electrospray Ionisation)
- FAB (Fast Atom Bombardment)
- EI (Electronic Impact)
- CI (Chemical Ionization)

 

REQUIMTE Laboratório Associado, CQFB, Departamento de Química (FCT/UNL)

Departamento de Química
Faculdade de Ciências e Tecnologia
Universidade Nova de Lisboa
2829-516 Caparica, Portugal

Tel (office): +351 212 948 386; ext. 10907
Lab: +351 212 948 300; ext. 10972
Fax: +351 212 948 550

Missions

At Present the main research line of Dr. Capelo belongs to analytical proteomics and metabolomics. Through drastic changes introduced in the sample treatments for proteomics using ultrasonication by Dr. Capelo´s research team, the standard procedures for protein and peptide identification has been reduced from days to seconds or few minutes. With the new ultra fast sample treatments, the identification of virus and bacteria is done in an easy and rapid manner, allowing rapid medical diagnosis for illnesses and infections. At present the protocols already published by Dr. Capelo are being used for the systematic identification of pathogens (salmonella), in collaboration with some hospitals of the Lisbon area. Furthermore, the simplification in the methodologies for the analysis and identification of steroids in blood or urine (analytical metabolomic) is a priority society´s demand in the fighting against the fraud in sport. At present, new approaches for the fast identification of steroids in urine are developed in the research team of Dr.Capelo.

Current Projects

Team

Dr. Jose Luis Capelo, Researcher

Dr. Carlos Lodeiro, Researcher

Dr. Joao Paulo Noronha, Researcher

Dr. Raquel Rial, Researcher

Gonçalo Vale, Undergraduate Student

Hugo Santos, MSc student

Ricardo Carreira, PhD student

Marco Galesio, BSc

Cristiano Mota

Diana Vieira

Top